PT Pyridam Farma Tbk (PYFA.JK)
IDR 179.0
(1.13%)
IDR 179.0
(1.13%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 986.99 Billion IDR | 8.46% |
| 2022 | 910.03 Billion IDR | 102.77% |
| 2021 | 448.81 Billion IDR | 1163.81% |
| 2020 | 35.51 Billion IDR | 82.96% |
| 2019 | 19.4 Billion IDR | -20.84% |
| 2018 | 24.52 Billion IDR | 138.84% |
| 2017 | 10.26 Billion IDR | -62.97% |
| 2016 | 27.72 Billion IDR | -17.2% |
| 2015 | 33.48 Billion IDR | -29.71% |
| 2014 | 47.64 Billion IDR | -5.85% |
| 2013 | 50.59 Billion IDR | 69.61% |
| 2012 | 29.83 Billion IDR | 85.77% |
| 2011 | 16.05 Billion IDR | 82.1% |
| 2010 | 8.81 Billion IDR | -43.74% |
| 2009 | 15.67 Billion IDR | -6.29% |
| 2008 | 16.72 Billion IDR | 2.01% |
| 2007 | 16.39 Billion IDR | 35.36% |
| 2006 | 12.11 Billion IDR | 44.48% |
| 2005 | 8.38 Billion IDR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1397.44 Billion IDR | 41.59% |
| 2024 Q3 | 1799.92 Billion IDR | -2.74% |
| 2024 Q2 | 3992.27 Billion IDR | 185.68% |
| 2023 Q4 | 986.99 Billion IDR | -0.08% |
| 2023 Q1 | 858.06 Billion IDR | -5.71% |
| 2023 Q2 | 898.51 Billion IDR | 4.71% |
| 2023 FY | 986.99 Billion IDR | 8.46% |
| 2023 Q3 | 987.81 Billion IDR | 9.94% |
| 2022 Q2 | 912.35 Billion IDR | 2.62% |
| 2022 FY | 910.03 Billion IDR | 102.77% |
| 2022 Q4 | 910.03 Billion IDR | 1.12% |
| 2022 Q1 | 889.03 Billion IDR | 98.09% |
| 2022 Q3 | 899.97 Billion IDR | -1.36% |
| 2021 Q3 | 347.95 Billion IDR | 5.97% |
| 2021 Q2 | 328.35 Billion IDR | 0.33% |
| 2021 Q1 | 327.26 Billion IDR | 821.53% |
| 2021 FY | 448.81 Billion IDR | 1163.81% |
| 2021 Q4 | 448.81 Billion IDR | 28.99% |
| 2020 Q1 | 20.85 Billion IDR | 7.47% |
| 2020 FY | 35.51 Billion IDR | 82.96% |
| 2020 Q4 | 35.51 Billion IDR | 56.98% |
| 2020 Q3 | 22.62 Billion IDR | 13.24% |
| 2020 Q2 | 19.97 Billion IDR | -4.23% |
| 2019 Q3 | 22.82 Billion IDR | -11.56% |
| 2019 Q4 | 19.4 Billion IDR | -14.97% |
| 2019 Q2 | 25.81 Billion IDR | -2.4% |
| 2019 FY | 19.4 Billion IDR | -20.84% |
| 2019 Q1 | 26.44 Billion IDR | 7.84% |
| 2018 Q1 | 27.84 Billion IDR | 171.16% |
| 2018 FY | 24.52 Billion IDR | 138.84% |
| 2018 Q4 | 24.52 Billion IDR | -22.08% |
| 2018 Q3 | 31.47 Billion IDR | -5.76% |
| 2018 Q2 | 33.39 Billion IDR | 19.96% |
| 2017 FY | 10.26 Billion IDR | -62.97% |
| 2017 Q2 | 28.29 Billion IDR | -6.37% |
| 2017 Q1 | 30.22 Billion IDR | 9.0% |
| 2017 Q3 | 16.85 Billion IDR | -40.42% |
| 2017 Q4 | 10.26 Billion IDR | -39.1% |
| 2016 Q3 | 23.65 Billion IDR | -18.2% |
| 2016 Q1 | 26.73 Billion IDR | -20.15% |
| 2016 FY | 27.72 Billion IDR | -17.2% |
| 2016 Q4 | 27.72 Billion IDR | 17.21% |
| 2016 Q2 | 28.91 Billion IDR | 8.15% |
| 2015 Q3 | 42.48 Billion IDR | -1.33% |
| 2015 FY | 33.48 Billion IDR | -29.71% |
| 2015 Q1 | 44.73 Billion IDR | -6.09% |
| 2015 Q2 | 43.05 Billion IDR | -3.76% |
| 2015 Q4 | 33.48 Billion IDR | -21.18% |
| 2014 Q4 | 47.64 Billion IDR | -2.41% |
| 2014 FY | 47.64 Billion IDR | -5.85% |
| 2014 Q3 | 48.81 Billion IDR | -2.12% |
| 2014 Q2 | 49.87 Billion IDR | -0.82% |
| 2014 Q1 | 50.28 Billion IDR | -0.62% |
| 2013 FY | 50.59 Billion IDR | 69.61% |
| 2013 Q2 | 48.07 Billion IDR | 60.6% |
| 2013 Q3 | 51.34 Billion IDR | 6.81% |
| 2013 Q4 | 50.59 Billion IDR | -1.45% |
| 2013 Q1 | 29.93 Billion IDR | 0.34% |
| 2012 Q1 | 12.69 Billion IDR | -20.97% |
| 2012 FY | 29.83 Billion IDR | 85.77% |
| 2012 Q2 | 18.85 Billion IDR | 48.58% |
| 2012 Q3 | 25.44 Billion IDR | 34.94% |
| 2012 Q4 | 29.83 Billion IDR | 17.24% |
| 2011 Q4 | 16.05 Billion IDR | 0.0% |
| 2011 FY | 16.05 Billion IDR | 82.1% |
| 2010 FY | 8.81 Billion IDR | -43.74% |
| 2009 FY | 15.67 Billion IDR | -6.29% |
| 2008 FY | 16.72 Billion IDR | 2.01% |
| 2007 FY | 16.39 Billion IDR | 35.36% |
| 2006 FY | 12.11 Billion IDR | 44.48% |
| 2005 FY | 8.38 Billion IDR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 1.47 Billion IDR | -66850.749% |
| PT Merck Tbk | 18.13 Billion IDR | -5343.154% |
| PT Phapros, Tbk | 802.57 Billion IDR | -22.978% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 9.39 Billion IDR | -10409.97% |
| PT Tempo Scan Pacific Tbk | 1116.39 Billion IDR | 11.591% |